Jasbir Seehra
CHIEF EXECUTIVE OFFICER · Keros Therapeutics, Inc.
- 2025
- Apr 6, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jasbir Seehra files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $95.66M in KROS purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
- Jean Jacques Bienaime - $76K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jasbir Seehra?
Jasbir Seehra is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jasbir Seehra last file a Form 4?
The most recent primary Form 4 on record is dated 6 April 2026, one of 5 filings going back to 2025.
Has Jasbir Seehra been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($113K) across all tracked filings.
